Table 1.
Clinical and pathologic features of 70 patients. (Data in parentheses are percentages)
| No. of evaluable patients | 70 |
|
| |
| Age, year | |
| Median | 71 |
|
| |
| Range | 36–92 |
|
| |
| Follow up time, months | |
| Median | 69.25 |
|
| |
| Range | 0–285.25 |
|
| |
| Stage | |
| I | 36 (51) |
|
| |
| II | 10 (14) |
|
| |
| III | 19 (27) |
|
| |
| IV | 5 (7) |
|
| |
| Subtype | |
| Endometriod | 42 (60) |
|
| |
| CCC+serous | 28 (40) |
|
| |
| Grade FIGO | |
| 1 | 16 (23) |
|
| |
| 2 | 16 (23) |
|
| |
| 3 | 38 (54) |
|
| |
| Grade Nuclear | |
| 1 | 10 (14) |
|
| |
| 2 | 22 (32) |
|
| |
| 3 | 38 (54) |
|
| |
| Tumor size, cm | |
| <=2 | 6 (9) |
|
| |
| >2 | 64 (91) |
|
| |
| Depth of invasion | |
| Median | 38 |
|
| |
| Range | (0–100) |
|
| |
| Recurrence | |
| N | 43 (61) |
|
| |
| Y | 23 (33) |
|
| |
| others | 4 (6) |
|
| |
| Status | |
| Alive with no evidence of disease (ANED) | 49 (70) |
|
| |
| Alive with evidence of disease (AWED) | 12 (17) |
|
| |
| Death of disease (DOD) | 7 (10) |
|
| |
| Death form other causes | 2 (1) |